Evelo Therapeutics Receives $35,000,000 Seed Financing Round

  • Feed Type
  • Date
    11/5/2015
  • Company Name
    Evelo Therapeutics
  • Mailing Address
    620 Memorial Drive West Cambridge, MA 02142 USA
  • Company Description
    Evelo Therapeutics has built a proprietary discovery, design and development platform based on a deep understanding of cancer associated bacteria (CAB) and bacterial immune activators (BIA™) to develop microbiome based therapies for cancer.
  • Website
    http://www.evelotx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $35,000,000
  • Transaction Round
    Seed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Undisclosed